US hospitals added 3,000 jobs in May to a seasonally adjusted 5,231,600, the Bureau of Labor Statistics reported June 7. That’s up 103,100 more employees than a year ago.
Overall, healthcare employment has increased 390,500 in the past year. The overall unemployment rate remained at a 50-year low of 3.6%.
In today’s ever-changing COVID environment, you and your surgical team may have questions and concerns. Please join us for a discussion on infection prevention strategies with special focus given to urology and ureteroscope reprocessing practices. Presenter Cori Ofstead, a global infection prevention thought leader, will share her insights on COVID in urine, scope reprocessing effectiveness and risk of infection transmission in urology, and recommendations for minimizing risk to protect patients and staff alike. Key discussion points during this moderated webinar will include recent findings on ureteroscope reprocessing effectiveness and how to better manage this during COVID and beyond.
Cori Ofstead has a master of science in public health and is CEO of Ofstead & Associates, Inc., where she leads a multidisciplinary team that specializes in designing and conducting real-world studies to validate healthcare guidelines, treatments, and product claims. As an epidemiologist with 25 years of research experience, Cori has conducted studies in dozens of facilities in diverse geographies. Her studies are published in peer-reviewed journals and cited in national standards and guidelines for endoscope reprocessing. She also serves as a preceptor for epidemiology graduate students at the University of Minnesota and a reviewer for the Journal of Urology, Endoscopy, Vaccine, and the American Journal of Infection Control. Cori has completed 10 studies on endoscope reprocessing in 19 facilities and has participated in several endoscope outbreak and breach investigations. She has audited sterile processing procedures in over 70 facilities and serves as a subject matter expert for guideline-issuing bodies.